TGTX Historical Cash Flow
| TGTX Stock | USD 28.53 0.81 2.76% |
Analysis of TG Therapeutics cash flow over time is an excellent tool to project TG Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Income of 12 M or Total Cash From Financing Activities of 61.8 M as it is a great indicator of TG Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining TG Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether TG Therapeutics is a good buy for the upcoming year.
TGTX |
About TGTX Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in TGTX balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which TGTX's non-liquid assets can be easily converted into cash.
TG Therapeutics Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from TG Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into TG Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TG Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy TGTX Stock please use our How to Invest in TG Therapeutics guide.At this time, TG Therapeutics' Other Non Cash Items is fairly stable compared to the past year. Net Income is likely to rise to about 12 M in 2025, despite the fact that Change In Cash is likely to grow to (8.9 M).
TG Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
TG Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
TG Therapeutics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 440.8M | (254.5M) | (196.6M) | (9.4M) | (9.4M) | (8.9M) | |
| Free Cash Flow | (214.9M) | (296.0M) | (176.2M) | (31.4M) | (28.3M) | (29.7M) | |
| Change In Working Capital | (19.8M) | (12.2M) | (1.6M) | (84.7M) | (76.2M) | (72.4M) | |
| Begin Period Cash Flow | 113.9M | 554.7M | 300.2M | 102.3M | 103.6M | 58.1M | |
| Other Cashflows From Financing Activities | 147K | (800K) | (20.0M) | 49.8M | 1.4M | 1.3M | |
| Other Non Cash Items | 4.0M | 2.4M | 4.1M | 128.8M | 2.2M | 2.3M | |
| Total Cash From Operating Activities | (214.5M) | (295.6M) | (176.2M) | (31.4M) | (28.3M) | (29.7M) | |
| Net Income | (279.4M) | (348.1M) | (198.3M) | 12.7M | 11.4M | 12.0M | |
| Total Cash From Financing Activities | 679.8M | 41.4M | (391K) | 72.7M | 83.6M | 61.8M | |
| End Period Cash Flow | 554.7M | 300.2M | 103.6M | 92.9M | 94.2M | 61.0M | |
| Depreciation | 374K | 494K | 515K | 423K | 486.5K | 510.8K | |
| Sale Purchase Of Stock | 175.0M | 679.8M | 2.4M | 584K | 671.6K | 638.0K | |
| Change To Account Receivables | (6K) | (1.4M) | 1.4M | (51.1M) | (46.0M) | (43.7M) | |
| Change To Liabilities | 23.8M | (22.0M) | (2.3M) | (11.2M) | (12.9M) | (12.3M) | |
| Total Cashflows From Investing Activities | (718K) | (24.5M) | (332K) | (20.0M) | (18.0M) | (17.1M) | |
| Other Cashflows From Investing Activities | (587K) | (24.2M) | 69K | (20.0M) | (18.0M) | (17.1M) | |
| Stock Based Compensation | 80.3M | 61.3M | 19.2M | 37.9M | 43.6M | 45.8M | |
| Cash And Cash Equivalents Changes | 70.7M | 440.8M | (254.5M) | (196.6M) | (176.9M) | (168.1M) | |
| Cash Flows Other Operating | 4.0M | 4.6M | (6.6M) | 10.9M | 9.8M | 10.3M | |
| Change To Netincome | 11.5M | 81.0M | 60.7M | 19.1M | 21.9M | 23.0M | |
| Net Borrowings | 29.2M | 40M | 39.0M | (975K) | (1.1M) | (1.1M) | |
| Investments | (24.5M) | 69K | (20.0M) | (50.7M) | (45.6M) | (43.3M) | |
| Change Receivables | (11K) | (6K) | (1.4M) | 1.4M | 1.6M | 1.7M | |
| Change To Operating Activities | 30.1M | (31.2M) | (26.7M) | 8.1M | 7.3M | 7.7M | |
| Issuance Of Capital Stock | 175.0M | 679.7M | 2.2M | 46.3M | 41.7M | 39.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for TGTX Stock Analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.